Antidiabetic medication: the drugs used by patients with type 2 diabetes at admission were dominated by glucose-lowering drugs (74%; OADs and GLP-1 receptor agonists) and insulin (25%), 77% of these patients receiving GLDs as add-on medication (Table 1), while only 20% were on a diet alone. The gene discussed is INS; the disease is type 2 diabetes mellitus.